Terms: = Head and neck cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
163 results:
1. Verification of the expression trend and interaction prediction of innate immune cells and immune-checkpoint molecules in the process of oral mucosal carcinogenesis.
Li K; Shi L; Liu L; Wang J; Nie M; Liu X
Hua Xi Kou Qiang Yi Xue Za Zhi; 2024 Apr; 42(2):192-206. PubMed ID: 38597079
[TBL] [Abstract] [Full Text] [Related]
2. RNA splicing regulator EIF3D regulates the tumor microenvironment through immunogene-related alternative splicing in head and neck squamous cell carcinoma.
Lu D; Mihoayi M; Ablikim Y; Arikin A
Aging (Albany NY); 2024 Mar; 16(7):5929-5948. PubMed ID: 38535990
[TBL] [Abstract] [Full Text] [Related]
3. M6A-mediated molecular patterns and tumor microenvironment infiltration characterization in nasopharyngeal carcinoma.
Wang Y; Peng L; Wang F
Cancer Biol Ther; 2024 Dec; 25(1):2333590. PubMed ID: 38532632
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic model revealing pyroptosis-related signatures in oral squamous cell carcinoma based on bioinformatics analysis.
Qi L; Tang Z
Sci Rep; 2024 Mar; 14(1):6149. PubMed ID: 38480853
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
[TBL] [Abstract] [Full Text] [Related]
6. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
Mestiri S; El-Ella DMA; Fernandes Q; Bedhiafi T; Almoghrabi S; Akbar S; Inchakalody V; Assami L; Anwar S; Uddin S; Gul ARZ; Al-Muftah M; Merhi M; Raza A; Dermime S
Biomed Pharmacother; 2024 Feb; 171():116095. PubMed ID: 38183744
[TBL] [Abstract] [Full Text] [Related]
7. Nivolumab in unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma.
Ikeda G; Miyakoshi J; Yamamoto S; Kato K
Future Oncol; 2024 Apr; 20(11):665-677. PubMed ID: 38126175
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of CD-57 expression in oral squamous cell carcinoma cases.
Kumar S; Chandra A; Agrawal R; Singh P; Pallavi M
Indian J Pathol Microbiol; 2023; 66(4):815-818. PubMed ID: 38084538
[TBL] [Abstract] [Full Text] [Related]
9. head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract] [Full Text] [Related]
10. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract] [Full Text] [Related]
11. Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma.
Jiang B; Tang M; Shi S; Xie H; Pan S; Zhang L; Sheng J
J Mol Histol; 2023 Dec; 54(6):633-644. PubMed ID: 37874500
[TBL] [Abstract] [Full Text] [Related]
12. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract] [Full Text] [Related]
13. Noninvasive radiomic analysis of enhanced CT predicts ctla4 expression and prognosis in head and neck squamous cell carcinoma.
Zhu Y; Wu M
Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
[TBL] [Abstract] [Full Text] [Related]
14. Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma.
Wang C; Zhou Y
J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):58. PubMed ID: 37697421
[TBL] [Abstract] [Full Text] [Related]
15. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.
Sordo-Bahamonde C; Lorenzo-Herrero S; Granda-Díaz R; Martínez-Pérez A; Aguilar-García C; Rodrigo JP; García-Pedrero JM; Gonzalez S
Mol Cancer; 2023 Aug; 22(1):142. PubMed ID: 37649037
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma.
Hirai H; Nakaguro M; Tada Y; Saigusa N; Kawakita D; Honma Y; Kano S; Tsukahara K; Ozawa H; Okada T; Okami K; Yamazaki K; Sato Y; Urano M; Kajiwara M; Utsumi Y; Shimura T; Fushimi C; Shimizu A; Kondo T; Imanishi Y; Sakai A; Sato Y; Togashi T; Hanazawa T; Matsuki T; Yamazaki K; Nagao T
Virchows Arch; 2023 Sep; 483(3):367-379. PubMed ID: 37464232
[TBL] [Abstract] [Full Text] [Related]
17. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma.
Huang S; Xiong C; Tan K
Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
[TBL] [Abstract] [Full Text] [Related]
18. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
[TBL] [Abstract] [Full Text] [Related]
19. Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and ctla-4 in patients with advanced solid tumors.
Ma Y; Xue J; Zhao Y; Zhang Y; Huang Y; Yang Y; Fang W; Guo Y; Li Q; Ge X; Sun J; Zhang B; Zhang Y; Xiao J; Zhang L; Zhao H
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37263673
[TBL] [Abstract] [Full Text] [Related]
20. The effect of surgical complications on long-term prognosis following oesophagectomy.
Broadbent A; Rahman S; Grace B; Walker R; Noble F; Kelly J; Byrne J; Underwood T
Eur J Surg Oncol; 2023 Oct; 49(10):106930. PubMed ID: 37258358
[TBL] [Abstract] [Full Text] [Related]
[Next]
